Compare Cita Mineral Investindo Tbk. (CITA) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cita Mineral Investindo Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Cita Mineral Investindo Tbk. trades at Rp3,150 (market cap 12.4T, 39.7K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,520 (market cap 11.18T, 613K 24h volume). The key difference: Cita Mineral Investindo Tbk. and Tempo Scan Pacific Tbk. are close in size by market cap, and Tempo Scan Pacific Tbk. is more actively traded (613K versus 39.7K). Which is the better fit depends on your goals.
| CITA | TSPC | |
|---|---|---|
Market Cap | 12.4T | 11.18T |
Volume | 39.7K | 613K |
Lot | 397 | 6.13K |
Turnover | 125.19M | 1.54B |
Average Price | 3,153.35 | 2,511.52 |
Value | 125.19M | 1.54B |
Indicative Equilibrium Price | — | 2,520 |
Indicative Equilibrium Volume | — | 17 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cita Mineral Investindo Tbk.
PT Cita Mineral Investindo Tbk based in Tanggerang established formerly under the name PT. Cipta Panelutama on June 27th 1992. Conduct in furniture manufacturing industry both production & marketing. Start the business in furniture panel production which made by particle board & medium density fibreboard to export to Euro and Arabic market. Type of product such as TV, Audio-Video Cable Cabinet, CD Holder, Computer Workstation & Home Entertainment Center.
Read more on CITA →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
